Explore the various treatment options available for Myelodysplastic Syndromes patients.
Supportive Care
The foundation of MDS treatment often begins with supportive care to manage symptoms and maintain quality of life:
- Blood transfusions to treat anemia
- Growth factors to stimulate blood cell production
- Antibiotics to prevent and treat infections
- Platelet transfusions for bleeding issues
Disease-Modifying Treatments
Hypomethylating Agents
Azacitidine and decitabine are FDA-approved for MDS treatment and work by reactivating genes that control cell growth.
Immunomodulatory Drugs
Lenalidomide is approved for specific subtypes of MDS with chromosome 5q deletion.
Stem Cell Transplant
Allogeneic stem cell transplant is the only potentially curative treatment for MDS, though it’s typically reserved for younger, healthier patients.
Clinical Trials
Many patients benefit from participating in clinical trials testing new therapies and combinations of treatments.
